Clinical Trial Update: A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS) [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study to assess the long-term safety of Tofersen (Qalsody) in Chinese participants with SOD-1–associated amyotrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Qalsody (Tofersen)

Snippet

Sponsor: Biogen | Conditions: Amyotrophic Lateral Sclerosis | Phase 4 | Status: RECRUITING